Reactome | SGN-CD33A: a novel CD33-targeting antibody-drug conjugate using a pyrrolobenzodiazepine dimer is active in models of drug-resistant AML

Schema > LiteratureReference > Entries

SGN-CD33A: a novel CD33-targeting antibody-drug conjugate using a pyrrolobenzodiazepine dimer is active in models of drug-resistant AML Show undefined attributes

author	[Person:9736438] Kung Sutherland, MS [Person:9736448] Walter, RB [Person:9736492] Jeffrey, SC [Person:9736499] Burke, PJ [Person:9736427] Yu, C [Person:9736503] Kostner, H [Person:9736430] Stone, I [Person:9736470] Ryan, MC [Person:9736434] Sussman, D [Person:9736472] Lyon, RP [Person:9736481] Zeng, W [Person:9736423] Harrington, KH [Person:9736425] Klussman, K [Person:9736446] Westendorf, L [Person:9736473] Meyer, D [Person:9736475] Bernstein, ID [Person:9736444] Senter, PD [Person:9736436] Benjamin, DR [Person:9736474] Drachman, JG [Person:9736459] McEarchern, JA
created	[InstanceEdit:9736450] Orlic-Milacic, Marija, 2021-07-12
dbId	9736463
displayName	SGN-CD33A: a novel CD33-targeting antibody-drug conjugate using a pyrrolobenzodiazepine dimer is active in models of drug-resistant AML
journal	Blood
pages	1455-63
pubMedIdentifier	23770776
schemaClass	LiteratureReference
title	SGN-CD33A: a novel CD33-targeting antibody-drug conjugate using a pyrrolobenzodiazepine dimer is active in models of drug-resistant AML
url	http://www.ncbi.nlm.nih.gov/pubmed/23770776
volume	122
year	2013

Referrals

(literatureReference)

[BlackBoxEvent:R-HSA-9713785] Anti-cancer drugs generate DNA interstrand crosslinks

(author)

© 2026 Reactome

Cite Us!